Status:
ACTIVE_NOT_RECRUITING
Evaluation of Green Tea for Improving Blood Lipid Profile
Lead Sponsor:
Taipei Medical University
Collaborating Sponsors:
Eagletek Corp.
Conditions:
Hypercholesterolemia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The objects of this study are to evaluate the effects of the "Heysong japanese green tea" on the human subjects who are dyslipidemia. In this trial, 40 healthy subjects whose ages are 18\~65 years old...
Eligibility Criteria
Inclusion
- Male and female. Age between 18-65 years old.
- Those who have been assessed as dyslipidemia by a family physician but have not yet required medication. The following measurement values were used as evaluation criteria:
- Hypercholesterolemia: plasma total cholesterol (TC) \>200 mg/dL;
- Mixed hyperlipidemia: plasma total cholesterol (TC) \>200 mg/dL , triglyceride (TG) \>200 mg/dL;
- Hypertriglyceridemia: plasma triglyceride (TG) \>200 mg/dL, and high-density lipoprotein cholesterol (HDL-C) \< 35 mg/dL or TC/HDL-C \>5.
Exclusion
- Pregnant, breastfeeding, menopausal women.
- Take any drugs or supplements that can affect blood lipid levels 2 weeks before or during the experiment.
- People with intolerance to caffeine or green tea.
- People who take drugs for chronic diseases.
- People who smoke or drink alcohol.
Key Trial Info
Start Date :
March 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2025
Estimated Enrollment :
38 Patients enrolled
Trial Details
Trial ID
NCT06992765
Start Date
March 15 2023
End Date
August 30 2025
Last Update
May 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Medical University
Taipei, Taiwan